Clinical data | |
---|---|
Other names | N-(2-Chlorophenyl)-3-oxo-4-aza-4-methylandrost-1-en-17α-carboxamide |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C26H33ClN2O2 |
Molar mass | 441.01 g·mol−1 |
3D model ( JSmol) | |
| |
|
Cl-4AS-1 is a dual anabolic–androgenic steroid (AAS) and 5α-reductase inhibitor. [1] [2] It is a potent and selective full agonist of the androgen receptor ( IC50 = 12 nM) and inhibitor of 5α-reductase types I and II (IC50 = 6 and 10 nM, respectively). [1] [2] Structurally, Cl-4AS-1 is a 4-azasteroid. [1]